Genedx LLC partnered with Illumina Inc. to test whether Illumina's constellation map read technology could shed light on hard ...
Collaboration and license agreement will advance Boehringer’s expanding antibody-drug conjugate (ADC) portfolio with a new asset expected to enter first-in-human studies next year.New, potentially bes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback